LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity

Area of Science:

• Molecular Biology
• Biochemistry
• Oncology

Background:

• Longevity Assurance 5 (LASS5), a ceramide synthase, is involved in tumor biology but its interactions are unclear.
• Understanding LASS5's molecular interactions is crucial for elucidating its role in cancer.

Purpose of the Study:

• To identify LASS5 interaction partners.
• To investigate the functional consequences of LASS5 and SDHB interaction in the context of tumor biology.

Main Methods:

• Yeast and mammalian two-hybrid assays.
• GST pull-down and co-immunoprecipitation assays.
• Cell co-localization and reporter gene assays.

Main Results:

• LASS5 interacts with succinate dehydrogenase subunit B (SDHB), requiring SDHB's C-terminal fragment.
• LASS5 and SDHB co-localize and are upregulated in neuroglioma.
• Both LASS5 and SDHB individually repress p53 and p21 reporter activity; their simultaneous expression shows synergistic repression.

Conclusions:

• LASS5 and SDHB form a molecular complex.
• The LASS5-SDHB interaction may play a synergistic role in the transcriptional regulation of p53 and p21.
• This interaction offers new molecular insights into the roles of LASS5 and SDHB in tumor biology.